Sara Rolandsson Enes
Has grant
Associate Professor, Regenerative Medicine
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Sara Rolandsson Enes is an Associate Professor in Regenerative Medicine at Lund University in Sweden. Her research focuses on mesenchymal stromal cells (MSCs) and their roles in conditions such as acute respiratory distress syndrome (ARDS), allergic asthma, and sepsis. Recent articles highlight her work on the therapeutic mechanisms of MSC-derived extracellular vesicles and their microRNA content in various lung conditions.
Recent Grants
Grant: Close
MSC polarisation towards a disease-specific anti-inflammatory phenotype in severe inflammatory lung disorders
Open Date: 2018-01-01
Close Date: 2020-12-01
Grant: Close
Disease-specific MSC-cell based therapy for severe inflammatory lung disorders
Open Date:
Close Date:
Grant: Close
Mesenkymala stromaceller/stamceller i human lungvävnad
Open Date:
Close Date:
Grant: Close
Mesenchymal stromal/stem cells in human lung tissue
Open Date:
Close Date:
Grant: Close
Mesenchymal stromal/stem cells in human lung tissue
Open Date:
Close Date:
Articles (10)
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (12)
Anna Krasnodembskaya
Reader
The Queen's University Belfast
Bernd Giebel
University Hospital Essen
Mareike Lehmann
Professor of Translational Inflammation Research
Philipps-Universität Marburg
Anne van der Does
Assistant Professor
Leiden University Medical Center
Natalia El-Merhie
Institute for Lung Health
David Simpson
Professor
The Queen's University Belfast
Karen English
Professor
Maynooth University
Cecilia M. O’Kane
-
Matthew Loxham
University of Southampton
Irma Mahmutovic Persson
Lund University
Lareb Dean
University of Southampton
Johnatas Dutra Silva
The Queen's University Belfast
Make your next move.
Prepare your application
Review drafts before you send them.